Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
The Journal of Investigative Dermatology|September 10, 2016
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib TreatmentMarcella Tazzari, Valentina Indio, Barbara Vergani, et al.
JAMA Oncology|June 4, 2026
PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression: A Systematic Review and Meta-AnalysisAlessandro Di Federico, Samuele Compagno, Francesco Mantuano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2023
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenibC Serrano, S Bauer, D Gómez-Peregrina, et al.
Therapeutic Advances in Medical Oncology|February 17, 2018
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practiceMargherita Nannini, Maria Concetta Nigro, Bruno Vincenzi, et al.
The Journal of Pathology|April 26, 2019
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomasMonica Brenca, Silvia Stacchiotti, Kelly Fassetta, et al.
Frontiers in Oncology|January 21, 2022
SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal TumorMaria A Pantaleo, Milena Urbini, Angela Schipani, et al.
Cancers|July 24, 2019
Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived XenograftSilvia Stacchiotti, Valentina Zuco, Monica Tortoreto, et al.
ESMO Open|August 9, 2024
TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma GroupC Fabbroni, G Grignani, B Vincenzi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 5, 2014
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutationsMaria A Pantaleo, Cristian Lolli, Margherita Nannini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2021
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III StudyYoon-Koo Kang, Suzanne George, Robin L Jones, et al.
Pageof 12